VYNE Therapeutics (VYNE) Short Interest Ratio & Short Volume $1.04 +0.04 (+4.00%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$1.08 +0.04 (+3.85%) As of 05/23/2025 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VYNE Therapeutics Short Interest DataVYNE Therapeutics (VYNE) has a short interest of 217,500 shares, representing 1.57% of the float (the number of shares available for trading by the public). This marks a 13.81% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.3, indicating that it would take 1.3 days of the average trading volume of 111,397 shares to cover all short positions.Current Short Interest217,500 sharesPrevious Short Interest191,100 sharesChange Vs. Previous Month+13.81%Dollar Volume Sold Short$289,275.00Short Interest Ratio1.3 Days to CoverLast Record DateApril 30, 2025Outstanding Shares15,210,000 sharesFloat Size13,890,000 sharesShort Percent of Float1.57%Today's Trading Volume1,329,449 sharesAverage Trading Volume111,397 sharesToday's Volume Vs. Average1,193% Short Selling VYNE Therapeutics? Sign up to receive the latest short interest report for VYNE Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVYNE Short Interest Over TimeVYNE Days to Cover Over TimeVYNE Percentage of Float Shorted Over Time VYNE Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2025217,500 shares $289,275.00 +13.8%1.6%1.3 $1.33 4/15/2025191,100 shares $347,802.00 +40.8%1.5%1.3 $1.82 3/31/2025135,700 shares $214,406.00 -9.8%1.1%1 $1.58 3/15/2025150,500 shares $278,425.00 +21.6%1.2%1.3 $1.85 2/28/2025123,800 shares $311,976.00 -11.4%1.0%1.2 $2.52 2/15/2025139,800 shares $345,306.00 +13.5%1.1%1.4 $2.47 1/31/2025123,200 shares $289,520.00 +9.7%1.0%1.1 $2.35 1/15/2025112,300 shares $309,948.00 +82.9%0.9%1 $2.76 12/31/202461,400 shares $205,690.00 -1.6%0.5%0.5 $3.35 12/15/202462,400 shares $159,744.00 -3.0%0.5%0.7 $2.56 Get the Latest News and Ratings for VYNE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for VYNE Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/202464,300 shares $190,328.00 -37.1%0.5%0.8 $2.96 11/15/2024102,200 shares $275,940.00 +23.7%0.8%1.3 $2.70 10/31/202482,600 shares $224,672.00 +65.2%0.7%1.2 $2.72 10/15/202450,000 shares $100,000.00 -14.1%0.4%1 $2.00 9/30/202458,200 shares $109,416.00 +75.8%0.5%1.3 $1.88 9/15/202433,100 shares $60,904.00 -28.8%0.3%0.7 $1.84 8/31/202446,500 shares $84,630.00 -20.0%0.4%0.9 $1.82 8/15/202458,100 shares $108,066.00 -13.0%0.5%1.1 $1.86 7/31/202466,800 shares $126,920.00 +8.1%0.5%1.3 $1.90 7/15/202461,800 shares $139,050.00 +10.6%0.5%1.1 $2.25 6/30/202455,900 shares $110,123.00 -10.9%0.5%1 $1.97 6/15/202462,700 shares $144,210.00 +22.2%0.5%0.7 $2.30 5/31/202451,300 shares $130,302.00 -10.6%0.4%0.6 $2.54 5/15/202457,400 shares $160,720.00 -30.0%0.5%0.6 $2.80 4/30/202482,000 shares $206,640.00 -15.3%0.7%0.8 $2.52 4/15/202496,800 shares $248,776.00 +13.1%0.8%0.9 $2.57 3/31/202485,600 shares $262,792.00 +590.3%0.7%0.7 $3.07 3/15/202412,400 shares $24,924.00 -63.4%0.1%0.1 $2.01 2/29/202433,900 shares $75,597.00 -5.3%0.3%0.3 $2.23 2/15/202435,800 shares $77,328.00 -31.8%0.3%0.4 $2.16 1/31/202452,500 shares $89,775.00 -40.3%0.4%0.5 $1.71 1/15/202488,000 shares $181,280.00 No Change0.7%0.2 $2.06 12/31/202388,000 shares $205,040.00 +1,157.1%N/A0.2 $2.33 12/15/20237,000 shares $19,180.00 -94.4%0.1%0 $2.74 11/30/2023124,800 shares $413,088.00 -15.0%1.0%0.4 $3.31 11/15/2023146,800 shares $604,816.00 +150.9%1.2%0.4 $4.12 10/31/202358,500 shares $178,425.00 +11.6%1.9%0.2 $3.05 10/15/202352,400 shares $144,100.00 -7.6%1.7%3.3 $2.75 9/30/202356,700 shares $229,068.00 -8.1%1.8%3.5 $4.04 9/15/202361,700 shares $237,545.00 -0.2%2.0%4.1 $3.85[INSIDE] Elon’s Next Move Could Send This AI Stock Soaring (Ad)Missed Nvidia? This Under-the-Radar AI Stock Could Be Next Musk's AI empire is just beginning — and one overlooked company could be at the center of it all. We reveal everything in this exclusive Memorial Day webinar.Reserve your spot before it's gone >>> 8/31/202361,800 shares $268,830.00 -19.7%2.0%3.7 $4.35 8/15/202377,000 shares $373,450.00 +13.1%2.4%3.7 $4.85 7/31/202368,100 shares $316,665.00 +3.8%2.2%2 $4.65 7/15/202365,600 shares $276,832.00 -6.0%2.1%0.7 $4.22 6/30/202369,800 shares $286,180.00 -5.6%2.2%0.1 $4.10 6/15/202373,900 shares $352,281.30 +13.7%2.4%0.1 $4.77 5/31/202365,000 shares $408,850.00 -29.3%2.1%0.1 $6.29 5/15/202391,900 shares $705,792.00 -55.6%2.9%0.1 $7.68 4/30/2023206,800 shares $1.09 million +119.1%6.6%0.3 $5.26 4/15/202394,400 shares $256,768.00 -3.9%3.0%0.1 $2.72 3/31/202398,200 shares $302,456.00 +30.2%3.1%1.7 $3.08 3/15/202375,400 shares $192,270.00 +38.1%2.3%1 $2.55 2/28/202354,600 shares $182,091.00 -2.5%1.7%0.8 $3.34 2/15/202356,000 shares $196,560.00 -94.6%1.8%0.8 $3.51 1/31/20231,030,000 shares $267,800.00 -29.0%N/A0.8 $0.26 1/15/20231,450,000 shares $388,311.45 +105.2%N/A1.2 $0.27 12/30/2022706,800 shares $106,020.00 -7.4%N/A0.6 $0.15 12/15/2022763,400 shares $129,472.64 -4.3%N/A3.5 $0.17 11/30/2022797,700 shares $185,545.02 +3.5%N/A4.3 $0.23 11/15/2022770,600 shares $189,297.89 -3.6%N/A4.3 $0.25 10/31/2022799,300 shares $204,301.08 +3.2%N/A2.7 $0.26 10/15/2022774,400 shares $187,792.00 +0.0%N/A2.6 $0.24 9/30/2022774,200 shares $172,724.02 -22.4%N/A2.6 $0.22 9/15/2022997,900 shares $282,405.70 +48.9%N/A3.1 $0.28 8/31/2022670,200 shares $209,973.66 -6.0%N/A1.9 $0.31 8/15/2022713,200 shares $228,224.00 -4.9%N/A1.9 $0.32 7/31/2022750,300 shares $324,204.63 -15.5%N/A2.5 $0.43 7/15/2022887,400 shares $399,330.00 -22.8%N/A2.6 $0.45 6/30/20221,150,000 shares $447,350.00 -9.5%N/A2 $0.39 6/15/20221,270,000 shares $660,400.00 +5.0%N/A2 $0.52 5/31/20221,210,000 shares $492,954.00 -11.7%N/A1.8 $0.41 5/15/20221,370,000 shares $545,260.00 -12.7%N/A2 $0.40 4/30/20221,570,000 shares $659,400.00 +8.3%N/A2.1 $0.42 4/15/20221,450,000 shares $767,050.00 +57.0%N/A1.7 $0.53 3/31/2022923,800 shares $600,562.38 -19.0%N/A0.8 $0.65 3/15/20221,140,000 shares $638,400.00 -22.5%N/A1 $0.56 2/28/20221,470,000 shares $796,740.00 -6.4%N/A0.5 $0.54 2/15/20221,570,000 shares $893,487.00 -23.4%N/A0.6 $0.57 1/31/20222,050,000 shares $1.27 million +12.6%N/A0.7 $0.62 1/15/20221,820,000 shares $1.25 million -12.5%N/A0.7 $0.69 12/31/20212,080,000 shares $2.12 million -34.0%N/A0.9 $1.02 12/15/20213,150,000 shares $3.59 million +283.4%N/A1.3 $1.14 11/30/2021821,600 shares $846,248.00 -11.7%N/A0.6 $1.03 11/15/2021930,900 shares $1.19 million +5.5%N/A1.3 $1.28 10/29/2021882,000 shares $1.18 million +1.5%1.7%1 $1.34 10/15/2021869,400 shares $1.06 million -9.6%1.7%1 $1.22 9/30/2021962,100 shares $1.34 million -23.0%1.9%1.3 $1.39 9/15/20211,250,000 shares $1.85 million -11.4%2.5%1.5 $1.48 8/31/20211,410,000 shares $2.40 million -50.4%2.8%1.6 $1.70 8/13/20212,840,000 shares $5.06 million -6.6%5.6%3.2 $1.78[INSIDE] Elon’s Next Move Could Send This AI Stock Soaring (Ad)Missed Nvidia? This Under-the-Radar AI Stock Could Be Next Musk's AI empire is just beginning — and one overlooked company could be at the center of it all. We reveal everything in this exclusive Memorial Day webinar.Reserve your spot before it's gone >>> 7/30/20213,040,000 shares $8.21 million +7.8%6.0%4.1 $2.70 7/15/20212,820,000 shares $7.76 million +9.7%5.6%3.2 $2.75 6/30/20212,570,000 shares $9.02 million -35.6%5.1%2.8 $3.51 6/15/20213,990,000 shares $14.52 million -1.2%7.9%4.6 $3.64 5/28/20214,040,000 shares $15.96 million -7.3%8.0%4.6 $3.95 5/14/20214,360,000 shares $14.13 million +15.7%8.6%4.4 $3.24 4/30/20213,770,000 shares $19.34 million +13.2%7.5%2.5 $5.13 4/15/20213,330,000 shares $18.78 million -0.9%6.6%1.4 $5.64 3/31/20213,360,000 shares $22.14 million +14.7%6.7%1.4 $6.59 3/15/20212,930,000 shares $21.65 million +7.7%5.8%1.3 $7.39 2/26/20212,720,000 shares $21.46 million -71.8%5.4%1.2 $7.89 2/12/20219,660,000 shares $102.78 million -7.9%19.7%4.8 $10.64 1/29/202110,490,000 shares $93.57 million +15.2%5.8%1.6 $8.92 1/15/20219,110,000 shares $60.13 million No Change5.7%2.4 $6.60 8/14/20209,960,000 shares $64.14 million -3.7%N/A2.2 $6.44 7/31/202010,340,000 shares $66.59 million +19.0%N/A2.1 $6.44 7/15/20208,690,000 shares $56.31 million -22.7%N/A1.7 $6.48 6/30/202011,240,000 shares $81.38 million +62.0%N/A2.1 $7.24 6/15/20206,940,000 shares $61.07 million +44.9%N/A1.4 $8.80 5/29/20204,790,000 shares $45.79 million +20.1%N/A1.2 $9.56 VYNE Short Interest - Frequently Asked Questions What is VYNE Therapeutics' current short interest? Short interest is the volume of VYNE Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 217,500 shares of VYNE short. 1.57% of VYNE Therapeutics' shares are currently sold short. Learn More on VYNE Therapeutics' current short interest. What is a good short interest ratio for VYNE Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VYNE shares currently have a short interest ratio of 1.0. Learn More on VYNE Therapeutics's short interest ratio. What is a good short interest percentage for VYNE Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.57% of VYNE Therapeutics' floating shares are currently sold short. Is VYNE Therapeutics' short interest increasing or decreasing? VYNE Therapeutics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 217,500 shares, an increase of 13.8% from the previous total of 191,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is VYNE Therapeutics' float size? VYNE Therapeutics currently has issued a total of 15,210,000 shares. Some of VYNE Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. VYNE Therapeutics currently has a public float of 13,890,000 shares. How does VYNE Therapeutics' short interest compare to its competitors? 1.57% of VYNE Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to VYNE Therapeutics: Adaptimmune Therapeutics plc (1.70%), Genenta Science S.p.A. (0.02%), Exicure, Inc. (1.15%), CytomX Therapeutics, Inc. (12.08%), Telomir Pharmaceuticals, Inc. (12.93%), ESSA Pharma Inc. (1.60%), Sutro Biopharma, Inc. (6.32%), Pyxis Oncology, Inc. (16.42%), Jasper Therapeutics, Inc. (14.56%), IGM Biosciences, Inc. (5.32%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short VYNE Therapeutics stock? Short selling VYNE is an investing strategy that aims to generate trading profit from VYNE Therapeutics as its price is falling. VYNE shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against VYNE Therapeutics? A short squeeze for VYNE Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VYNE, which in turn drives the price of the stock up even further. How often is VYNE Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VYNE, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Adaptimmune Therapeutics Short Interest Data Genenta Science Short Interest Data Exicure Short Interest Data CytomX Therapeutics Short Interest Data Telomir Pharmaceuticals Short Interest Data ESSA Pharma Short Interest Data Sutro Biopharma Short Interest Data Pyxis Oncology Short Interest Data Jasper Therapeutics Short Interest Data IGM Biosciences Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VYNE) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding VYNE Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share VYNE Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VYNE Stock Free VYNE Stock Alerts